Fisher Asset Management LLC decreased its position in Merit Medical Systems Inc. (NASDAQ:MMSI) by 21.8% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 145,380 shares of the company’s stock after selling 40,417 shares during the period. Fisher Asset Management LLC owned 0.33% of Merit Medical Systems worth $3,531,000 as of its most recent SEC filing.

A number of other institutional investors have also recently made changes to their positions in the company. Macquarie Group Ltd. increased its position in shares of Merit Medical Systems by 27.5% in the second quarter. Macquarie Group Ltd. now owns 874,579 shares of the company’s stock worth $17,343,000 after buying an additional 188,865 shares in the last quarter. Mason Street Advisors LLC purchased a new position in shares of Merit Medical Systems during the second quarter worth $172,000. Aristotle Capital Boston LLC increased its position in shares of Merit Medical Systems by 3.5% in the second quarter. Aristotle Capital Boston LLC now owns 424,961 shares of the company’s stock worth $8,427,000 after buying an additional 14,552 shares in the last quarter. Schwab Charles Investment Management Inc. increased its position in shares of Merit Medical Systems by 0.8% in the second quarter. Schwab Charles Investment Management Inc. now owns 362,632 shares of the company’s stock worth $7,191,000 after buying an additional 2,760 shares in the last quarter. Finally, Elk Creek Partners LLC increased its position in shares of Merit Medical Systems by 12.7% in the second quarter. Elk Creek Partners LLC now owns 793,932 shares of the company’s stock worth $15,744,000 after buying an additional 89,236 shares in the last quarter. 90.29% of the stock is owned by institutional investors and hedge funds.

Institutional Ownership by Quarter for Merit Medical Systems (NASDAQ:MMSI)

Merit Medical Systems Inc. (NASDAQ:MMSI) traded down 1.26% during midday trading on Wednesday, reaching $23.55. 295,652 shares of the company’s stock were exchanged. Merit Medical Systems Inc. has a 12-month low of $15.47 and a 12-month high of $25.10. The company has a market cap of $1.05 billion, a price-to-earnings ratio of 56.07 and a beta of 0.91. The firm has a 50-day moving average price of $23.03 and a 200 day moving average price of $22.15.

Merit Medical Systems (NASDAQ:MMSI) last announced its quarterly earnings data on Wednesday, October 26th. The company reported $0.26 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.23 by $0.03. Merit Medical Systems had a net margin of 3.25% and a return on equity of 8.85%. The company earned $157 million during the quarter, compared to analysts’ expectations of $155.06 million. During the same quarter in the prior year, the company earned $0.20 EPS. The firm’s revenue was up 15.4% on a year-over-year basis. On average, analysts expect that Merit Medical Systems Inc. will post $1.00 EPS for the current fiscal year.

ILLEGAL ACTIVITY WARNING: “Fisher Asset Management LLC Has $3,531,000 Position in Merit Medical Systems Inc. (MMSI)” was posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this report on another publication, it was illegally stolen and reposted in violation of U.S. and international copyright legislation. The correct version of this report can be read at https://www.thecerbatgem.com/2016/11/30/fisher-asset-management-llc-has-3531000-position-in-merit-medical-systems-inc-mmsi.html.

A number of equities analysts recently weighed in on the stock. Zacks Investment Research downgraded shares of Merit Medical Systems from a “buy” rating to a “hold” rating in a research note on Tuesday, November 1st. Canaccord Genuity set a $29.00 target price on shares of Merit Medical Systems and gave the stock a “buy” rating in a research note on Monday, October 24th. Two investment analysts have rated the stock with a hold rating, two have issued a buy rating and one has given a strong buy rating to the company. Merit Medical Systems has a consensus rating of “Buy” and an average target price of $24.00.

Merit Medical Systems Company Profile

Merit Medical Systems, Inc is a designer, developer, manufacturer and marketer of medical devices used in an array of interventional and diagnostic procedures. The Company operates in two segments: cardiovascular and endoscopy. Its cardiovascular segment consists of cardiology and radiology devices, which assist in diagnosing and treating coronary arterial disease, peripheral vascular disease and other non-vascular diseases; embolotherapeutic products, and cardiac rhythm management and electrophysiology (CRM/EP) devices.

5 Day Chart for NASDAQ:MMSI

Receive News & Stock Ratings for Merit Medical Systems Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merit Medical Systems Inc. and related stocks with our FREE daily email newsletter.